Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH

Febrile neutropenia is a major complication of the treatment of patients with hematologic diseases. Recent epidemiologic changes, with an increase in infection caused by drug-resistant bacteria, represent a major challenge for the proper management of febrile neutropenia. The impact of these changes in the epidemiology of infection may vary according to the region. In this document we present recommendations from the Infectious Diseases Committee of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy (ABHH) for the management of febrile neutropenia in hematologic patients. The consensus was developed by ten experts in the field, using the Delphi methodology. In the document we provide recommendations for the initial workup, prophylaxis, empiric antibiotic and antifungal therapy, modifications in the empiric regimen and criteria for discontinuing antimicrobial therapy.

Authors

Institutions

Publication Details

Journal
Hematology Transfusion and Cell Therapy
Published
2024-12-01
DOI
https://doi.org/10.1016/j.htct.2024.11.119
Citations
3
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
0.85
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH

Márcio Nucci, Maria Daniela Bergamasco, Celso Arrais‐Rodrigues, Belinda Pinto Simões et al.
3 citations
Hematology Transfusion and Cell Therapy
Neutropenia and Cancer Infections
0.85
article

Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH

Márcio Nucci, Maria Daniela Bergamasco, Celso Arrais‐Rodrigues, Belinda Pinto Simões, Jéssica Fernandes Ramos, Mariana Guaraná, Clarisse Martins Machado, Marco Aurélio Salvino, Márcia Garnica, Ana Glória
article en
3 citations

Abstract

Febrile neutropenia is a major complication of the treatment of patients with hematologic diseases. Recent epidemiologic changes, with an increase in infection caused by drug-resistant bacteria, represent a major challenge for the proper management of febrile neutropenia. The impact of these changes in the epidemiology of infection may vary according to the region. In this document we present recommendations from the Infectious Diseases Committee of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy (ABHH) for the management of febrile neutropenia in hematologic patients. The consensus was developed by ten experts in the field, using the Delphi methodology. In the document we provide recommendations for the initial workup, prophylaxis, empiric antibiotic and antifungal therapy, modifications in the empiric regimen and criteria for discontinuing antimicrobial therapy.

Hematology Transfusion and Cell TherapyVol. 46
Universidade Federal de Minas Gerais (BR), Universidade Federal do Rio de Janeiro (BR), Universidade Federal da Bahia (BR), Universidade de São Paulo (BR), Hospital Israelita Albert Einstein (BR), Hospital Universitário Gaffrée e Guinle (BR), Hospital Amaral Carvalho (BR), Hospital Universitário Antônio Pedro (BR), Hospital Sírio-Libanês (BR), Hospital São Paulo (BR)
Good health and well-being
Openalex Percentile: Top 21%
Neutropenia and Cancer Infections
0.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.